Cód QR

Hemophilia prophylaxis adherence and bleeding using a tailored, frequency‐escalated approach: The Canadian Hemophilia Primary Prophylaxis Study

Abstract Background Standard of care for persons with severe hemophilia A includes regular replacement of factor VIII (FVIII). Prophylaxis regimens using standard half‐life (SHL) FVIII concentrates, while effective, are costly and require frequent intravenous infusions. Aim This study evaluated the...

Cur síos iomlán

Sábháilte in:
Príomhchruthaitheoirí: Saunya Dover, Victor S. Blanchette, Darius Wrathall, Eleanor Pullenayegum, Daniel Kazandjian, Byron Song, Sue Ann Hawes, Stéphanie Cloutier, Geroges E. Rivard, Robert J. Klaassen, Elizabeth Paradis, Nicole Laferriere, Ann Marie Stain, Anthony K. Chan, Sara J. Israels, Roona Sinha, MacGregor Steele, John K. M. Wu, Brian M. Feldman
Formáid: Artigo
Teanga:Inglês
Foilsithe / Cruthaithe: Elsevier 2020-02-01
Sraith:Research and Practice in Thrombosis and Haemostasis
Ábhair:
bleeding
factor VIII
hemophilia A
prophylaxis
treatment adherence and compliance
Rochtain ar líne:https://doi.org/10.1002/rth2.12301
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla